Redox Regulation of Metastasis by Sod2
Sod2 对转移的氧化还原调节
基本信息
- 批准号:6755946
- 负责人:
- 金额:$ 14.85万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2002
- 资助国家:美国
- 起止时间:2002-07-01 至 2006-06-30
- 项目状态:已结题
- 来源:
- 关键词:biological signal transductionbiotechnologycell linecollagenasegene expressiongenetic polymorphismgenetic transcriptionguanine nucleotide binding proteinhydrogen peroxideimmunocytochemistrylaboratory mousemanganesemetastasismitogen activated protein kinaseneoplasm /cancer invasivenessnorthern blottingsoxidation reduction reactionpolymerase chain reactionsuperoxide dismutasetissue /cell culturetransfectiontransfection /expression vectorwestern blottings
项目摘要
DESCRIPTION (provided by applicant): These studies will evaluate the role of
the mitochondrial manganese superoxide dismutase (Sod2) in the regulation of
matrix metalloproteinase (MMP) expression and metastatic invasion. We have
established that the Sod2-dependent H202 production is sufficient and required
for MMP-1 expression. The ability of Sod2 overexpression to modulate MMP
expression appears to be dependent on signaling through Ras and the ERK1/2
cascade. This signaling cascade may be utilized under a variety of conditions
where Sod2 levels are elevated. We have also established that invasion,
metastasis and MMP expression are enhanced in an H202-dependent fashion when
Sod2 is overexpressed. These observations may explain a number of reports
suggesting that Sod2 overexpression is linked to an increase in metastatic
cancers. More importantly we have shown that Sod2 and MMP-1 functionally
interact. This latter observation is quite provocative, as SNPs in either of
these proteins have independently been linked to increased incidence of
various forms of cancer. It has been proposed that the Sod2 polymorphism
increases its activity. Our findings indicate that increases in Sod2 activity
can increase the transcriptional activity of both the native and polymorphic
MMP-1 promoter. Furthermore, only subtle changes in Sod2 levels are required
to modulate MMP-1 expression. The proposed studies will: (1) establish the
link between Sod2, MMPs and metastasis, (2) define the molecular mechanisms
that modulate MMP expression in response to Sod2-dependent production of H2O2,
(3) determine if a synergy between the Sod2 and MMP-1 levels or polymorphisms
exist, and (4) develop redox-based adenoviral vectors that target metastatic
tumor cells for destruction.
描述(由申请者提供):这些研究将评估
线粒体锰超氧化物歧化酶(Sod2)在细胞周期调控中的作用
基质金属蛋白酶(MMPs)表达与肿瘤转移我们有
确定依赖于Sod2的H202生产是足够和必需的
用于基质金属蛋白酶-1的表达。Sod2过表达对基质金属蛋白酶的调节作用
表达似乎依赖于通过RAS和ERK1/2的信号
卡斯卡德。这种信令级联可以在各种条件下使用
Sod2水平升高的地方。我们还证实了入侵,
在H202依赖的方式下,转移和基质金属蛋白酶的表达增强
Sod2基因过度表达。这些观察结果可以解释一些报告。
提示Sod2的过度表达与转移癌的增加有关
癌症。更重要的是,我们已经证明了Sod2和MMP-1在功能上
互动。后一种观察结果非常具有挑衅性,因为这两个基因中的任何一个
这些蛋白质已经独立地与增加的发病率有关。
各种形式的癌症。已有研究提出Sod2基因的多态
增加了它的活动。我们的发现表明,Sod2活性的增加
可以提高原生和多态基因的转录活性
基质金属蛋白酶-1启动子。此外,只需要对Sod2级别进行细微的更改
调节基质金属蛋白酶-1的表达。建议的研究将会:(1)确立
Sod2、MMPs与肿瘤转移的关系:(2)明确分子机制
调节基质金属蛋白酶的表达,以响应依赖于Sod2的过氧化氢的产生,
(3)确定Sod2和MMP1水平或多态之间是否存在协同作用
存在,以及(4)开发以氧化还原为基础的针对转移的腺病毒载体
等着销毁肿瘤细胞。
项目成果
期刊论文数量(17)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Concise handbook of familial cancer susceptibility syndromes - second edition.
- DOI:10.1093/jncimonographs/lgn001
- 发表时间:2008-01-01
- 期刊:
- 影响因子:0
- 作者:Lindor, Noralane M;McMaster, Mary L;Greene, Mark H
- 通讯作者:Greene, Mark H
Cumulative impact of common genetic variants and other risk factors on colorectal cancer risk in 42,103 individuals.
- DOI:10.1136/gutjnl-2011-300537
- 发表时间:2013-06
- 期刊:
- 影响因子:24.5
- 作者:Dunlop MG;Tenesa A;Farrington SM;Ballereau S;Brewster DH;Koessler T;Pharoah P;Schafmayer C;Hampe J;Völzke H;Chang-Claude J;Hoffmeister M;Brenner H;von Holst S;Picelli S;Lindblom A;Jenkins MA;Hopper JL;Casey G;Duggan D;Newcomb PA;Abulí A;Bessa X;Ruiz-Ponte C;Castellví-Bel S;Niittymäki I;Tuupanen S;Karhu A;Aaltonen L;Zanke B;Hudson T;Gallinger S;Barclay E;Martin L;Gorman M;Carvajal-Carmona L;Walther A;Kerr D;Lubbe S;Broderick P;Chandler I;Pittman A;Penegar S;Campbell H;Tomlinson I;Houlston RS
- 通讯作者:Houlston RS
Mutation deep within an intron of MSH2 causes Lynch syndrome.
- DOI:10.1007/s10689-011-9427-0
- 发表时间:2011-06
- 期刊:
- 影响因子:2.2
- 作者:Clendenning M;Buchanan DD;Walsh MD;Nagler B;Rosty C;Thompson B;Spurdle AB;Hopper JL;Jenkins MA;Young JP
- 通讯作者:Young JP
Analysis of families with Lynch syndrome complicated by advanced serrated neoplasia: the importance of pathology review and pedigree analysis.
- DOI:10.1007/s10689-009-9238-8
- 发表时间:2009
- 期刊:
- 影响因子:2.2
- 作者:Walsh, Michael D.;Buchanan, Daniel D.;Walters, Rhiannon;Roberts, Aedan;Arnold, Sven;McKeone, Diane;Clendenning, Mark;Ruszkiewicz, Andrew R.;Jenkins, Mark A.;Hopper, John L.;Goldblatt, Jack;George, Jillian;Suthers, Graeme K.;Phillips, Kerry;Young, Graeme P.;Macrae, Finlay;Drini, Musa;Woods, Michael O.;Parry, Susan;Jass, Jeremy R.;Young, Joanne P.
- 通讯作者:Young, Joanne P.
Acquisition of the metastatic phenotype is accompanied by H2O2-dependent activation of the p130Cas signaling complex.
- DOI:10.1158/1541-7786.mcr-12-0478
- 发表时间:2013-03
- 期刊:
- 影响因子:0
- 作者:Hempel N;Bartling TR;Mian B;Melendez JA
- 通讯作者:Melendez JA
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JUAN Andres MELENDEZ其他文献
JUAN Andres MELENDEZ的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JUAN Andres MELENDEZ', 18)}}的其他基金
相似海外基金
A novel producer cell line for more efficient manufacturing of viral vector systems
用于更有效地制造病毒载体系统的新型生产细胞系
- 批准号:
10597799 - 财政年份:2023
- 资助金额:
$ 14.85万 - 项目类别:
Developing a stable cell line expressing recombinant sclerostin
开发表达重组硬化素的稳定细胞系
- 批准号:
10385037 - 财政年份:2022
- 资助金额:
$ 14.85万 - 项目类别:
Model-driven Media Optimization in Hybridoma Cell Line
杂交瘤细胞系中模型驱动的培养基优化
- 批准号:
7154904 - 财政年份:2006
- 资助金额:
$ 14.85万 - 项目类别:
A basic study on the development of bioartificial pancreas using a highly differentiated human pancreatic beta cell line.
使用高度分化的人胰腺β细胞系开发生物人工胰腺的基础研究。
- 批准号:
18390347 - 财政年份:2006
- 资助金额:
$ 14.85万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Homologous Recombination in a Secretory Mouse Cell Line
分泌型小鼠细胞系中的同源重组
- 批准号:
6683289 - 财政年份:2001
- 资助金额:
$ 14.85万 - 项目类别:
Homologous Recombination in a Secretory Mouse Cell Line
分泌型小鼠细胞系中的同源重组
- 批准号:
6572294 - 财政年份:2001
- 资助金额:
$ 14.85万 - 项目类别:
NOVEL E1 CELL LINE FOR RCA-FREE ADENOVIRAL GENE THERAPY
用于无 RCA 腺病毒基因治疗的新型 E1 细胞系
- 批准号:
6211901 - 财政年份:2001
- 资助金额:
$ 14.85万 - 项目类别:
MOLECULAR CLONING OF A T(15;19) IN LUNG CANCER CELL LINE
肺癌细胞系中 T(15;19) 的分子克隆
- 批准号:
6845072 - 财政年份:2000
- 资助金额:
$ 14.85万 - 项目类别:
MOLECULAR CLONING OF A T(15;19) IN LUNG CANCER CELL LINE
肺癌细胞系中 T(15;19) 的分子克隆
- 批准号:
6619443 - 财政年份:2000
- 资助金额:
$ 14.85万 - 项目类别: